"M42 "Expecting a memorandum of understanding with the Uzbek Ministry of Health to cooperate in the field of genome science
Abu Dhabi, January 29/ WAM/ “M42” signed a memorandum of understanding with the Ministry of Health in Uzbekistan, to cooperate and explore the opportunities for strategic partnerships within the Uzbek Genome program, in a move within the framework of the ambitious efforts made by the M42 to enhance its imprint in the genome science and increase its contribution to the genomic diversity Global.
It was signed during a ceremony at the Rotana Beach Hotel in Abu Dhabi, attended by His Excellency Suhail bin Muhammad Faraj Faris Al Mazrouei, Minister of Energy and Infrastructure, and His Excellency Aziz Kudratov, Minister of Investment, Industry and Trade in Uzbekistan.
The memorandum signed Farkodgon Tashbolatov, Deputy Minister of Health, Shukkhkh Ghulamov, Deputy Minister of Investment, in Uzbekistan, and Dr. Fahd Al Marzouki, Vice President of Operations of the Group in the M42.
According to the memo, the M42 shares with the Uzbek Ministry of Health to adhere to the promotion of their strategic partnership in the field of genome to achieve health care goals in Uzbekistan.
The memorandum aims to cooperate in the areas of genome science, advanced prevention methodologies, advanced examination and diagnostic techniques in the Republic of Uzbekistan and seek projects, including developing the capabilities of genome science/ omeglass research in the country in support of the Uzbek genome program and the formation of a new understanding of genetic diversity and diseases in Uzbekistan, design, development and manufacture of examination tools And a diagnostic diagnosis and related locally and regionally, to improve the capabilities of early identification and prevention.
Cooperation also includes supporting the application of prevention programs from genetic diseases in a manner that includes pre -marriage checks, newborn examination and prenatal surgical examinations, and expanding examinations for other diseases such as cancer and cardiovascular diseases,
Supporting, developing, developing, manufacturing and exporting new examination and diagnostic techniques manufactured in Uzbekistan, exchanging knowledge and training and refining the skills of work cadres.
And based on the experiences of the M42 in the Emirati genome program, in which it cooperated with the healthcare bodies and institutions in the UAE, which witnessed the establishment of a comprehensive genetic database for citizens that enabled doctors and researchers to identify unique genetic factors that contribute to facing the risk of genetic diseases in the country, this partnership will work between M42 and the Uzbek Ministry of Health to explore the opportunities to establish, operate and transfer a form of genome science in a way that benefits citizens in Uzbekistan, by treating diseases, enhancing early detection and supporting the transformation of the health care sector in the country towards the prevention model.
Farhakodgon Tashbatov, Deputy Minister of Health in Uzbekistan, said that genome research provides unique opportunities to understand genetic features of citizens in Uzbekistan, establish programs directed to early diagnosis and disease prevention, and we are proud to participate in such a global genome research in order to improve the health of the population and reduce the burdens of chronic diseases.
He added that through the strategic partnership with the M42, we are working to develop the capabilities of our national health system and contribute to global efforts to explore genetic diversity. Peritally for our state in the health care sector, stressing that the development and application of the program will be a solid pillars of new standards in prevention, diagnosis and treatment.
For his part, Hassan Jassim Al -Nuwais, Managing Director, CEO of the M42 Group, Chairman of the Cleveland Clinic Hospital Abu Dhabi, said that the “M42” partnership with the Ministry of Health in Uzbekistan represents a qualitative shift for the Uzbek health care system and its people and the diversity of global genome research as well, and with the lack of diversity of genome research, then The inhabitants of the world who do not have adequate representation in these studies are unable to seize vital benefits, starting with advanced clinical care to the early diagnosis of diseases and the design of studied medicines.
He added that based on the success of the Emirati genome program, it is expected for the Uzbek Genome program to contribute to the efforts of the global health care gaps bridge and play an important role in treating genetic diseases from their root Chronic for the people of Uzbekistan.
In turn, Dr. Fahd Al Marzouqi, Executive Vice President of the Group Operations in the M42, said that through cooperation with the Ministry of Health in Uzbekistan, we work together within the genome science to upgrade the health care sector in the country from the form of response to the disease to the preventive care methodology, which is with great health benefits on Citizens in Uzbekistan.
He added: “We succeeded in M42 by establishing a strong engine for genome science that provides integrated capabilities that lead to one of the largest genome programs in the world, and we have come a long way in this vital field, and we are proud to cooperate with countries such as Uzbekistan within its national programs for the genome, and we look forward to continuing cooperation with the Ministry Health in Uzbekistan is part of this important initiative to improve health justice around the world. “
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
